Epirubicin Hydrochloride

• Dose monitoring of commonly used cytostatic drugs for breast cancer Pending
  2024-514818-12-00 Phase IV 1 country Karolinska Institutet
• A study to test the effect of chemotherapy before surgery compared to surgery alone in patients with high risk retroperitoneal sarcoma. Recruiting
  2023-505261-84-00 Phase III 10 countries European Organisation For Research And Treatment Of Cancer
• CLINICAL TRIAL TO EVALUATE BLADDER INSTILLATION OF NEOADJUVANT CHEMOTHERAPY TO TRANSURETHRAL RESECTION OF THE BLADDER FOR THE PREVENTION OF … Recruiting
  2024-512683-53-00 Phase IV 1 country Hospital Universitario La Paz
• Serial cardiac magnetic resonance imaging (CMR) with contrast agents and biomarker analysis for the detection of cardiotoxicity under anthr… Recruiting
  2025-521573-14-00 Phase IV 1 country Robert Bosch Gesellschaft fuer medizinische Forschung mbH
• A clinical study of sac-TMT in people with breast cancer (MK-2870-032) Recruiting
  2024-520190-12-00 Phase III 14 countries Merck Sharp & Dohme LLC
• A clinical study of patritumab deruxtecan in people with breast cancer Recruiting
  2024-514376-40-00 Phase II 1 country Merck Sharp & Dohme LLC
• zAvatar test-guided therapeutic decision vs standard of care, in relapsed ovarian cancer and in metastatic breast cancer - A multicentric ra… Recruiting
  2023-509598-22-01 Phase IV 1 country Champalimaud Clinical Centre; Rita Fior
• A prospective, multicentre, open-label, randomized, Phase II study of Pembrolizumab in combination with neo-adjuvant EC-Paclitaxel regimen i… Recruiting
  2024-514899-41-00 Phase II 1 country Institut Paoli Calmettes
• 68Ga-FAPI-46 PET/CT for predicting histological response in triple-negative breast cancer Recruiting
  2023-507860-37-00 Phase I/II 1 country Institut Curie
• Study to compare the activation of the immune system depending on the chemotherapy scheme used together with PEMBROLIZUM (immunotherapy) in … Recruiting
  2023-507008-30-00 Phase II 1 country Champalimaud Clinical Centre
• A Randomized Trial of Trastuzumab Deruxtecan and Biology-Driven Selection of Neoadjuvant Treatment for HER2-positive Breast Cancer Recruiting
  2022-501504-95-00 Phase II 3 countries Karolinska University Hospital
• A Phase II study of post-operative palbociclib as an alternative to chemotherapy in older patients with localized breast cancer at high risk… Ended
  2023-505223-31-00 Phase II 7 countries European Organisation For Research And Treatment Of Cancer
• SWOG S1007: A Phase III, Randomized Clinical Trial of Standard Adjuvant Endrocrine Therapy +/- Chemotheraphy in Patients with 1-3 Positive N… Ended
  2024-516801-22-00 Phase III 1 country Cancer Trials Ireland
• Epirubicin for the Treatment of Sepsis & Septic Shock Ended
  2024-515776-12-00 Phase II 1 country Friedrich-Schiller-Universitaet Jena
• A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negati… Ended
  2023-508472-11-00 Phase III 2 countries NSABP Foundation Inc.

Showing 1–15 of 15 trials